Phreesia, Inc. (PHR) Q4 2026 Earnings Call Transcript
Beyond analysts' top-and-bottom-line estimates for Phreesia (PHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended January 2026.
Phreesia (PHR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Phreesia is at a pivotal growth stage, achieving GAAP profitability and strong adjusted EBITDA momentum. PHR's AccessOne acquisition enhances its platform with payment and financing capabilities, supporting margin expansion and revenue quality. Despite conservative FY2026 guidance and technical headwinds, PHR trades at a significant discount to peers, with improving fundamentals.
Phreesia (PHR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Yesterday we were watching whether Phreesia's path to profitability would accelerate after two consecutive near-breakeven quarters.
Phreesia, Inc. (PHR) Q3 2026 Earnings Call Transcript
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Besides Wall Street's top-and-bottom-line estimates for Phreesia (PHR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended October 2025.
Phreesia (PHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The heavy selling pressure might have exhausted for Phreesia (PHR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Phreesia's stock fell post-earnings for the first time since June 2024 amid apparent disappointment with the company's largest-ever acquisition. Yet improving cash flow margin and net income trends continue to make the stock a buy. This non-cyclical growth story still has plenty of runway as the company works to expand into its large TAM opportunities.